Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
about
Mechanism by which metformin reduces glucose production in type 2 diabetesRole of AMP-activated protein kinase in mechanism of metformin actionMetabolic actions of metformin in the heart can occur by AMPK-independent mechanismsMetformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscleMetformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trialMetformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsExtended-release metformin versus immediate-release metformin for type 2 diabetes mellitusOral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusOral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitusExtended-release metformin versus immediate-release metformin for type 2 diabetes mellitusNutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylationClinical significance of cardiovascular dysmetabolic syndromeDiabetes DyslipidemiaCurrent understanding of metformin effect on the control of hyperglycemia in diabetesAlternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic InflammationUse of metformin in diseases of agingTreating the elderly diabetic patient: special considerationsPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseAging and adipose tissue: potential interventions for diabetes and regenerative medicineThe relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes StudyComparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic reviewRho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in miceMetformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent BiosynthesisTreating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbsA genome-wide siRNA screen to identify modulators of insulin sensitivity and gluconeogenesisCancer: fundamentals behind pH targeting and the double-edged approachPrenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthoodThe effects of indoor and outdoor temperature on metabolic rate and adipose tissue - the Mississippi perspective on the obesity epidemic.Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.DISTq: An Iterative Analysis of Glucose Data for Low-Cost, Real-Time and Accurate Estimation of Insulin SensitivityEffect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus.Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancerLack of Effects of Metformin and AICAR Chronic Infusion on the Development of Hypertension in Dahl Salt-Sensitive RatsMetformin-associated lactic acidosis: a rare or very rare clinical entity?18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure.Current therapeutic options in type 2 diabetes.Effect of combined treatment with clozapine and metformin on fasting blood glucose, insulin level, and expression of the glucose transporter-2 (GLUT2) in Sprague-Dawley rats.Glucose supply and insulin demand dynamics of antidiabetic agents.
P2860
Q22241286-D7967E05-E141-463C-9660-8E4E734DCE85Q22241898-88B9913F-D818-4932-98A8-913D34A8AC26Q22241963-5A24BEB3-5520-4329-AE9C-B1FDF98904A8Q22241966-2BE1E9AA-3B24-4ED0-8F8C-535BC2345915Q22242637-32CFCF94-9AC0-4D14-BC2E-9FC5E5736995Q22242884-1443254C-CCB4-4364-AD40-87F88AEF94C9Q24195166-ECE26AF4-CEA9-4FB4-B9CE-D12DD6ECB4EEQ24234519-20826A97-77F2-43C3-B6B9-B6592829B6FDQ24235718-98CBDC07-0B41-4C1D-8A86-DCF0D0CE61FAQ24240522-42D2523A-FFC9-49FA-9568-640F1037D9D8Q24240792-53CBD71E-9072-4F7C-979C-D954D3C6C4E1Q24245977-7F55E9F1-36FB-4D61-BC7E-70E66D1FCCABQ24535576-FA742707-AD7B-465E-8C1B-7DEDFE1F958FQ24794239-F8C85B44-9672-433E-8AE8-CD09CDFF5FDBQ26750905-2D0218CD-C34E-46B8-B57E-D4397B217EB8Q26770236-72B73D26-D5AD-488A-BFE6-072705AC8225Q26801343-EFF68003-2DCC-4AED-92B2-4DC2166CAA6AQ26828760-C8C1FB14-28BE-4AA6-92DB-45260B5911CCQ26995176-9E5DAD0C-7C36-484F-8EDC-8B3135970E2EQ27027920-DA99365B-6628-413C-9ABD-6486DCC50806Q28079178-4981E0E6-6FDF-409B-BB77-30148470BE24Q28345534-6FCBE93E-ECCA-462F-B020-FF4E5ECA5A09Q28540671-594193AF-A379-489A-A0C5-4607A9CF619DQ28544668-1334C341-E1AB-449F-9D35-C21CCD5A8930Q28551227-99425B54-5AD3-40D8-9996-03D1E013D22DQ28687165-10497638-0761-464D-A608-F3EC5006E81AQ28730046-5FD2476C-2133-4065-93B1-6FF67CB7F17BQ28821351-C3B63032-446D-42B5-92BA-2DB92F81F725Q30428511-31971072-2C0E-4770-8115-DD6D79DBA8E3Q31095165-704D54B8-491D-475D-B6D9-045F3E2E4203Q31115487-D7F03451-E8CF-445A-B1AB-264A24807B41Q33530626-5E43411C-C1B3-4137-8C7F-1506920A738FQ33558365-849476C8-7204-4F55-AC0A-10F0E443F7EFQ33567263-2F4B0904-2820-4D19-AAD2-2B402C5B4AFEQ33581391-41124974-9157-485B-BF2F-66CD773EF554Q33603791-D0D43C09-9125-494E-A49A-8A87ABAD1C5BQ33626631-8AE0FB33-5439-4984-8055-CA2FE2D6D29AQ33670815-A8013381-BCF1-4F22-9896-4362B8FCF8CBQ33744440-A793ECB3-75D0-47EE-9B8A-FA946505F4BEQ33828255-47D2F2BC-9589-41AF-B0D9-C38C0D65AFEB
P2860
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@ast
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@en
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@nl
type
label
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@ast
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@en
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@nl
prefLabel
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@ast
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@en
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@nl
P2093
P1476
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.
@en
P2093
P304
P356
10.1056/NEJM199508313330903
P407
P577
1995-08-01T00:00:00Z